4Q Revenues: $342.7 million (+7%)
4Q Earnings: $23.6 million (+12%)
FY Revenues: $1.4 billion (+8%)
FY Earnings: $112.3 (+39%)
Comments: Pharmaceutical Packaging Systems (PPS) sales in the quarter were $241.5 million, up 6%. Standard packaging component sales grew 5% and high-value products grew 4%, excluding currency effects. Pharmaceutical Delivery Systems (PDS) sales were $101.8 million in the quarter, up 8%. R&D costs increased 13% to $9.7 million in the quarter, primarily due to increasing investments in high-value products development.